Aster DM Healthcare balance sheet

As of Mar 2026

Total assets: ₹8,112cr+22.8% on Mar 2025
Shareholders' equity: ₹4,834cr+32.4% on Mar 2025
Total debt: ₹701cr+9.2% on Mar 2025
Cash and investments: ₹229cr+38.2% on Mar 2025

₹ crore except per share

Tap a line for its trend	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

Current assets
Non-current assets					FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	2,619	3,628	2,880	4,629
	413	291	170	255
	264	264	264	1,160
	19.3	28.1	31.2	3,264
	7.0	2.3	0.2	23.9
	194	231	0.0	0.0
	971	12.3	13.7	68.3
	1.3	1.3	167	112
	136	84.0	104	210
	1,109	97.6	284	390
	36.2	6.2	121	45.6
	1,504	157	75.3	192
	6,164	4,705	3,826	9,960
	91.2	92.4	111	1,306
	1.4	1.4	3.3	11.3
	307	258	233	2,336
	228	165	82.2	379
	1,097	1,215	30.4	50.0
	159	116	39.9	189
	1,793	1,755	389	2,965
	64.0	53.7	65.3	651
	1,948	1,901	565	4,922
	0.0	0.0	13,600	0.0
	8,112	6,606	17,991	14,881
Equity
	518	500	500	500
	4,058	2,929	4,060	3,949
	4,576	3,428	4,560	4,448
	258	223	470	412
	4,834	3,651	5,030	4,860
Liabilities
	558	484	446	1,312
	1,493	1,352	897	3,371
	2,051	1,835	1,343	4,683
	53.4	41.8	33.1	407
	133	146	248	238
	0.0	0.0	49.1	37.1
	2,299	2,076	1,673	5,365
	143	158	223	975
	482	426	459	2,988
	120	219	123	368
	744	803	805	4,331
	12.1	4.7	5.0	109
	0.0	0.0	0.8	19.3
	214	61.7	60.9	196
	979	879	871	4,655
	0.0	0.0	10,417	0.0
	3,278	2,955	12,961	10,021
	8,112	6,606	17,991	14,881
Liabilities — additional as-filed lines
	9.4	9.5	0.0	0.0
	61.8	52.6	0.0	0.0
Trade payables — MSME split
	44.4	19.5	—	—
	437	407	—	—

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

ASTERDM₹669.45

Aster DM Healthcare Ltd.

· Pharma & Health

₹ CrorePeersAPOLLOHOSP MAXHEALTH KIMS COHANCE WOCKPHARMA SYNGENE GLAND LALPATHLABMcap ₹34,686 Cr

View

In ₹ Crore except Per Share As of	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Non-current Assets
+ Property, Plant & Equipment	4,628.6	2,879.9	3,627.8	2,618.7	2,618.7
+ Capital Work-in-Progress	255.1	170.1	290.7	412.6	412.6
+ Goodwill	1,159.7	264.1	264.1	264.1	264.1
+ Other Intangibles	3,264.2	31.2	28.1	19.3	19.3
+ Intangibles under Development	23.9	0.2	2.3	7.0	7.0
+ Investments (Equity Method)	0.0	0.0	231.4	193.9	193.9
+ Non-current Investments	68.3	13.7	12.3	971.3	971.3
+ Long-term Loans	111.9	166.9	1.3	1.3	1.3
+ Other Non-current Financial Assets	210.1	103.6	84.0	136.3	136.3
Non-current Financial Assets	390.3	284.3	97.6	1,108.8	1,108.8
+ Deferred Tax Assets	45.6	121.0	6.2	36.2	36.2
+ Other Non-current Assets	192.4	75.3	156.7	1,503.6	1,503.6
Total Non-current Assets	9,959.6	3,826.0	4,704.9	6,164.2	6,164.2
Current Assets
+ Inventories	1,305.6	110.5	92.4	91.2	91.2
+ Current Investments	11.3	3.3	1.4	1.4	1.4
+ Trade Receivables	2,336.3	233.4	257.8	307.2	307.2
+ Cash & Cash Equivalents	378.5	82.2	164.6	228.1	228.1
+ Other Bank Balances	50.0	30.4	1,215.4	1,097.3	1,097.3
+ Other Current Financial Assets	188.8	39.9	116.2	158.6	158.6
Current Financial Assets	2,965.0	389.2	1,755.4	1,792.6	1,792.6
+ Other Current Assets	651.0	65.3	53.7	64.0	64.0
Total Current Assets	4,921.6	565.0	1,901.5	1,947.8	1,947.8
+ Assets Held for Sale	0.0	13,600.3	0.0	0.0	0.0
Total Assets	14,881.2	17,991.3	6,606.4	8,112.0	8,112.0
Equity
+ Equity Share Capital	499.5	499.5	499.5	518.1	518.1
+ Other Equity / Reserves	3,948.6	4,060.3	2,928.6	4,057.7	4,057.7
Equity — Owners of Parent	4,448.1	4,559.8	3,428.1	4,575.9	4,575.9
+ Minority Interest	412.4	470.3	223.4	257.8	257.8
Total Equity	4,860.5	5,030.1	3,651.5	4,833.7	4,833.7
Liabilities
+ Borrowings — Non-current	1,312.3	446.1	483.7	558.4	558.4
+ Other Non-current Financial Liab	3,370.9	897.0	1,351.5	1,492.6	1,492.6
Non-current Financial Liabilities	4,683.2	1,343.1	1,835.3	2,051.1	2,051.1
+ Provisions — Non-current	407.1	33.1	41.8	53.4	53.4
+ Deferred Tax Liabilities	238.1	247.6	146.1	132.8	132.8
+ Other Non-current Liabilities	37.1	49.1	0.0	0.0	0.0
Non-current Liabilities	5,365.5	1,672.9	2,075.7	2,299.1	2,299.1
+ Borrowings — Current	975.2	223.2	158.5	142.7	142.7
+ Trade Payables	2,987.8	458.7	426.2	481.5	481.5
+ Other Current Financial Liab	368.0	122.6	218.7	119.6	119.6
Current Financial Liabilities	4,331.0	804.6	803.4	743.9	743.9
+ Provisions — Current	109.3	5.0	4.7	12.1	12.1
+ Current Tax Liabilities	19.3	0.8	0.0	0.0	0.0
+ Other Current Liabilities	195.7	60.9	61.7	213.9	213.9
Current Liabilities	4,655.3	871.2	879.2	979.2	979.2
+ Liabilities Held for Sale	0.0	10,417.0	0.0	0.0	0.0
Total Liabilities	10,020.7	12,961.2	2,954.9	3,278.3	3,278.3
Total Equity & Liabilities	14,881.2	17,991.3	6,606.4	8,112.0	8,112.0
Liabilities — additional as-filed lines
+ Deferred Government Grants — Current	0.0	0.0	9.5	9.4	9.4
+ Deferred Government Grants — Non-current	0.0	0.0	52.6	61.8	61.8
Trade Payables — MSME split
+ Dues to Micro & Small — Current	—	—	19.5	44.4	44.4
+ Dues to Other Creditors — Current	—	—	406.7	437.1	437.1

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.